Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
At a glance
Conditions
NCT06000319
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Alabama Back Institute
Jasper, Alabamano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Mark A Prevost Sr, MD · PRINCIPAL_INVESTIGATOR · Alabama Back Institute
- Mark A Prevost II, MD · PRINCIPAL_INVESTIGATOR · Alabama Back Institute
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Incidence of interbody fusionBaseline to 12 months post-operative
Flexion and Extensions radiographs will be assessed for fusion at each level to be fused Fusion is defined as: (1) less than 5 degrees of motion by flexion extension X-ray and (2) no radiological features of non-union (radiolucency, implant migration, loss of graft height, supplemental fixation failure). Both fusion criteria have to be met to be considered a fusion success at the index level.
- Incidence of secondary surgical interventionBaseline to 12 months post-operative
Secondary surgical interventions (SSI) include revision, re-operation, removal, or supplemental fixation at the index levels
- Incidence of Adverse Product Related EventsBaseline to 12 months post-operative
the incidence of the following will be reported: bone resorption with cage migration or subsidence, local inflammation with seromas, ectopic bone formation, radiculitis.